All articles tagged with #imidazole propionate
A study suggests that oral bacteria like Streptococcus mutans can migrate to the gut, produce metabolites such as ImP, and potentially contribute to Parkinson’s disease by affecting neurons and promoting neuroinflammation, highlighting new therapeutic targets involving the microbiome.
Scientists have identified a molecule called imidazole propionate produced by gut bacteria that can trigger atherosclerosis by causing arterial inflammation and plaque buildup, with potential for new treatments and dietary prevention strategies.
Spanish researchers discovered that a molecule produced by gut bacteria, imidazole propionate, causes atherosclerosis by triggering inflammation in arteries, independent of cholesterol levels. This breakthrough suggests new prevention and treatment strategies, including blocking the molecule's receptor, and highlights the significant role of gut microbiome in cardiovascular health.